Trial intelligence / Profile preview

Insulin-HF pilot study in heart failure and type 2 diabetes

2018-001057-26Phase 2Terminated

Sponsor
Mario Negri Institute for Pharmacological Research
Start
Nov 2020
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of human insulin in heart failure (HF), type 2 diabetes mellitus (T2DM), sponsored by Mario Negri Institute for Pharmacological Research. Started Nov 2020; status: terminated.

02

Drugs

human insulin
03

Conditions

heart failure (HF)type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on 2018-001057-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-001057-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call